Professional Summary
Ms. Chettih practices in all areas of intellectual property law. The focus of her current work is in patent litigation involving the pharmaceutical industry, including cases brought under the Hatch-Waxman Act. Ms. Chettih has represented clients in Federal courts in numerous jurisdictions, including the Court of Appeals for the Federal Circuit. Ms. Chettih also advises clients on federal regulation of the pharmaceutical industry and on their patent portfolios, including the preparation of opinions on patent validity, infringement and freedom to operate.

Education
J.D., New York University School of Law, 1980
M.I.A., Columbia University School of International and Public Affairs, 1984
B.A., Bard College, 1975

Admissions
New York
U.S. District Courts for the Southern and Eastern Districts of New York
U.S. Court of Appeals for the Federal Circuit

Memberships
Association of the Bar of the City of New York
American Intellectual Property Law Association

Decisions
Pharm.Res., Inc. and Par Pharm., Inc. v. Roxane Labs., Inc., U.S. Court of Appeals for the Federal Circuit, 2007-1093, - 1134 (Fed. Cir. October 26, 2007).

Savient Pharmaceuticals, Inc. v. Sandoz, Inc., No. 2007-1081, 2007 U.S. App. LEXIS 2800, 2007 WL 419358 (Fed. Cir. Jan. 25, 2007) (order dismissing proceeding).

Pharm. Res., Inc. v. Roxane Labs. Inc., No. 03-3357, 2006 U.S. Dist. LEXIS 81628, 2006 WL 3231427 (D.N.J. Nov. 8, 2006).

Novartis Pharm. Corp. v. Eon Labs Mfg., Inc., 363 F.3d 1306 (Fed. Cir. 2004).

Bristol-Myers Squibb Co. v. Ben Venue Labs., Inc., 246 F.3d 1368 (Fed. Cir. 2001).